Lv11
60 积分 2025-07-18 加入
THU-178 Siglec-5 is a functional biomarker that contributes to poor prognosis in patients with liver cirrhosis
42分钟前
求助中
Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency Ablation
2个月前
已完结
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
2个月前
已完结
Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade
2个月前
已完结
Aptamer‐based Immune Checkpoint Inhibition for Cancer Immunotherapy
4个月前
已完结
Siglecs: From Biomodulation to Immunotherapy
4个月前
已完结
Erythromycin Repurposing for Hepatocellular Carcinoma Treatment: Targeting CD24 to Enhance Anti-Tumor Immunity
4个月前
已完结
Role and regulation mechanism of Gal-3 in non-small cell lung cancer and its potential clinical therapeutic significance
4个月前
已完结
皖公网安备34019202002308
